Patient-reported satisfaction with telemedicine in light chain (AL) amyloidosis care

Amyloid. 2024 Sep;31(3):235-237. doi: 10.1080/13506129.2024.2344160. Epub 2024 May 20.

Authors

Idayat Akinola¹, Kathryn E Flynn¹, Aniko Szabo², Muriel Finkel³, Anita D'Souza¹

Affiliations

¹ Department of Medicine, Division of Hematology/Oncology, Medical College of WI, Milwaukee, WI, USA.
² Division of Biostatistics, Institute for Health & Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
³ Amyloidosis Support Groups, Inc., Phoenix, AZ, USA.

PMID: 38764391
PMCID: PMC11330728 (available on 2025-09-01)
DOI: 10.1080/13506129.2024.2344160

No abstract available

MeSH terms

Aged
Female
Humans
Immunoglobulin Light-chain Amyloidosis* / diagnosis
Immunoglobulin Light-chain Amyloidosis* / therapy
Male
Middle Aged
Patient Satisfaction*
Telemedicine*

Grants and funding